Concepts (236)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
Death, Sudden, Cardiac | 2 | 2019 | 522 | 1.03 | Why? |
Athletes | 5 | 2019 | 1047 | 1.03 | Why? |
Exercise | 13 | 2020 | 6771 | 1.00 | Why? |
Troponin I | 2 | 2020 | 1298 | 0.85 | Why? |
Erythrocytes | 4 | 2020 | 617 | 0.81 | Why? |
Erythrocyte Indices | 2 | 2020 | 207 | 0.78 | Why? |
Amiodarone | 1 | 2020 | 110 | 0.77 | Why? |
Cardiomyopathy, Hypertrophic | 2 | 2018 | 193 | 0.73 | Why? |
Clinical Chemistry Tests | 1 | 2018 | 82 | 0.71 | Why? |
PPAR delta | 1 | 2017 | 9 | 0.71 | Why? |
Connexin 43 | 1 | 2017 | 37 | 0.70 | Why? |
Hematuria | 1 | 2019 | 284 | 0.70 | Why? |
Cardiovascular Diseases | 5 | 2020 | 11497 | 0.67 | Why? |
Antithrombins | 1 | 2020 | 353 | 0.66 | Why? |
Tobacco Smoke Pollution | 1 | 2019 | 181 | 0.65 | Why? |
Epigenomics | 1 | 2017 | 139 | 0.63 | Why? |
AMP-Activated Protein Kinases | 1 | 2016 | 93 | 0.63 | Why? |
Calcitonin | 1 | 2017 | 201 | 0.62 | Why? |
Coronary Artery Disease | 3 | 2019 | 2570 | 0.60 | Why? |
Atrial Fibrillation | 2 | 2020 | 2320 | 0.55 | Why? |
Protein Precursors | 1 | 2017 | 425 | 0.53 | Why? |
Troponin T | 2 | 2018 | 771 | 0.53 | Why? |
Pulmonary Artery | 1 | 2021 | 803 | 0.52 | Why? |
Angiotensin Receptor Antagonists | 2 | 2020 | 3892 | 0.52 | Why? |
Physical Endurance | 3 | 2018 | 107 | 0.50 | Why? |
Polymorphism, Genetic | 1 | 2020 | 1074 | 0.49 | Why? |
Myocardial Ischemia | 1 | 2019 | 781 | 0.49 | Why? |
Thiazoles | 1 | 2017 | 496 | 0.47 | Why? |
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2021 | 1510 | 0.46 | Why? |
Vascular Diseases | 1 | 2020 | 846 | 0.44 | Why? |
Coronavirus Infections | 21 | 2020 | 253789 | 0.44 | Why? |
Peptidyl-Dipeptidase A | 4 | 2020 | 9659 | 0.43 | Why? |
Pneumonia, Viral | 21 | 2020 | 243684 | 0.42 | Why? |
Limit of Detection | 1 | 2018 | 2698 | 0.41 | Why? |
Sports | 1 | 2018 | 690 | 0.41 | Why? |
Electronic Nicotine Delivery Systems | 1 | 2017 | 561 | 0.39 | Why? |
Cardiovascular System | 1 | 2017 | 750 | 0.39 | Why? |
Blood Pressure | 2 | 2018 | 2198 | 0.37 | Why? |
Biomarkers, Tumor | 1 | 2017 | 1314 | 0.36 | Why? |
Betacoronavirus | 19 | 2020 | 204454 | 0.36 | Why? |
Renin-Angiotensin System | 2 | 2020 | 3661 | 0.34 | Why? |
Pandemics | 24 | 2021 | 389249 | 0.34 | Why? |
Heart Rate | 1 | 2017 | 1527 | 0.34 | Why? |
Risk Assessment | 6 | 2020 | 25439 | 0.33 | Why? |
Running | 3 | 2018 | 153 | 0.33 | Why? |
Arrhythmias, Cardiac | 1 | 2020 | 2510 | 0.32 | Why? |
Severity of Illness Index | 5 | 2020 | 48226 | 0.32 | Why? |
Angiotensin-Converting Enzyme Inhibitors | 2 | 2020 | 5277 | 0.29 | Why? |
African Americans | 1 | 2020 | 3363 | 0.28 | Why? |
Humans | 64 | 2021 | 930598 | 0.28 | Why? |
Resistance Training | 2 | 2017 | 273 | 0.27 | Why? |
Bacterial Infections | 1 | 2017 | 2229 | 0.26 | Why? |
Myocardial Infarction | 1 | 2020 | 3361 | 0.26 | Why? |
Mortality | 2 | 2020 | 7132 | 0.26 | Why? |
Receptors, Virus | 1 | 2020 | 5659 | 0.25 | Why? |
Prognosis | 7 | 2021 | 32490 | 0.24 | Why? |
Obesity | 2 | 2020 | 7388 | 0.24 | Why? |
Health Status Disparities | 1 | 2020 | 4072 | 0.24 | Why? |
Risk Factors | 12 | 2021 | 71621 | 0.23 | Why? |
Diabetes Mellitus | 2 | 2020 | 8207 | 0.22 | Why? |
Inflammatory Bowel Diseases | 1 | 2017 | 3209 | 0.21 | Why? |
Signal Transduction | 1 | 2016 | 7207 | 0.20 | Why? |
Internet | 1 | 2018 | 6204 | 0.20 | Why? |
Heart Failure | 2 | 2018 | 6638 | 0.19 | Why? |
Severe Acute Respiratory Syndrome | 2 | 2020 | 12361 | 0.19 | Why? |
Inflammation | 2 | 2020 | 13255 | 0.19 | Why? |
Coronary Angiography | 2 | 2019 | 2275 | 0.19 | Why? |
Lipopolysaccharide Receptors | 1 | 2021 | 357 | 0.19 | Why? |
Angiotensins | 1 | 2020 | 259 | 0.18 | Why? |
Chromatin Immunoprecipitation | 1 | 2017 | 53 | 0.18 | Why? |
Hypertension | 1 | 2020 | 8895 | 0.18 | Why? |
Mushroom Poisoning | 1 | 2017 | 10 | 0.18 | Why? |
Urinalysis | 1 | 2019 | 218 | 0.17 | Why? |
Aorta | 1 | 2021 | 355 | 0.17 | Why? |
Anti-Arrhythmia Agents | 1 | 2020 | 325 | 0.17 | Why? |
Alcohol-Related Disorders | 1 | 2018 | 84 | 0.17 | Why? |
Sodium Bicarbonate | 1 | 2017 | 54 | 0.17 | Why? |
Growth Differentiation Factor 15 | 1 | 2017 | 89 | 0.16 | Why? |
Urine | 1 | 2019 | 469 | 0.16 | Why? |
Cardiorespiratory Fitness | 1 | 2021 | 313 | 0.16 | Why? |
Diabetes Mellitus, Type 2 | 1 | 2018 | 6166 | 0.16 | Why? |
Diet | 2 | 2020 | 2052 | 0.16 | Why? |
Platelet Function Tests | 1 | 2017 | 231 | 0.15 | Why? |
Respiratory Muscles | 1 | 2017 | 116 | 0.15 | Why? |
Global Health | 1 | 2019 | 13911 | 0.15 | Why? |
Breathing Exercises | 1 | 2017 | 118 | 0.15 | Why? |
Erythrocyte Deformability | 1 | 2014 | 15 | 0.15 | Why? |
Enzyme Activation | 1 | 2016 | 425 | 0.15 | Why? |
Arachidonic Acid | 1 | 2015 | 90 | 0.14 | Why? |
Muscle Strength | 1 | 2017 | 317 | 0.14 | Why? |
Weight Gain | 1 | 2020 | 552 | 0.14 | Why? |
Comorbidity | 4 | 2020 | 34796 | 0.14 | Why? |
Fibrinogen | 2 | 2018 | 1048 | 0.14 | Why? |
DNA Damage | 1 | 2017 | 285 | 0.14 | Why? |
MicroRNAs | 2 | 2018 | 1787 | 0.14 | Why? |
Eicosapentaenoic Acid | 1 | 2015 | 106 | 0.14 | Why? |
Muscle, Skeletal | 2 | 2018 | 915 | 0.13 | Why? |
Health Status | 2 | 2019 | 3259 | 0.13 | Why? |
Prescription Drugs | 1 | 2017 | 243 | 0.13 | Why? |
Longevity | 1 | 2015 | 159 | 0.13 | Why? |
Phosphorylation | 1 | 2016 | 1060 | 0.12 | Why? |
Lipocalins | 1 | 2012 | 19 | 0.12 | Why? |
Syndrome | 1 | 2018 | 1310 | 0.12 | Why? |
Rhabdomyolysis | 1 | 2017 | 287 | 0.12 | Why? |
DNA Methylation | 1 | 2017 | 688 | 0.12 | Why? |
Observational Studies as Topic | 1 | 2020 | 1887 | 0.12 | Why? |
Physical Fitness | 3 | 2021 | 334 | 0.12 | Why? |
Metabolic Syndrome | 1 | 2020 | 810 | 0.12 | Why? |
Fluid Therapy | 1 | 2017 | 628 | 0.12 | Why? |
Exercise Test | 1 | 2018 | 911 | 0.11 | Why? |
Disseminated Intravascular Coagulation | 1 | 2020 | 994 | 0.11 | Why? |
Exercise Tolerance | 1 | 2017 | 634 | 0.11 | Why? |
Healthy Volunteers | 1 | 2017 | 1444 | 0.11 | Why? |
Biomarkers | 6 | 2021 | 23361 | 0.11 | Why? |
Myalgia | 1 | 2017 | 1015 | 0.11 | Why? |
Lipids | 1 | 2018 | 1079 | 0.11 | Why? |
Acute-Phase Proteins | 1 | 2012 | 177 | 0.11 | Why? |
Coronavirus | 1 | 2020 | 18339 | 0.11 | Why? |
Reactive Oxygen Species | 1 | 2017 | 1136 | 0.11 | Why? |
Peptide Fragments | 1 | 2021 | 2075 | 0.11 | Why? |
Natriuretic Peptide, Brain | 1 | 2018 | 1215 | 0.11 | Why? |
Body Mass Index | 2 | 2021 | 4306 | 0.10 | Why? |
Recovery of Function | 1 | 2020 | 2461 | 0.10 | Why? |
Proto-Oncogene Proteins | 1 | 2012 | 340 | 0.10 | Why? |
Gastrointestinal Tract | 1 | 2017 | 1113 | 0.10 | Why? |
Exercise Therapy | 1 | 2017 | 976 | 0.09 | Why? |
Quarantine | 3 | 2020 | 18418 | 0.09 | Why? |
Sequence Analysis, DNA | 1 | 2017 | 2830 | 0.09 | Why? |
Thrombophilia | 1 | 2020 | 1935 | 0.09 | Why? |
Monocytes | 1 | 2021 | 2978 | 0.09 | Why? |
Asymptomatic Diseases | 1 | 2020 | 3444 | 0.09 | Why? |
Antihypertensive Agents | 1 | 2020 | 1962 | 0.09 | Why? |
Heparin | 1 | 2020 | 2600 | 0.09 | Why? |
Hypertension, Pulmonary | 1 | 2017 | 970 | 0.08 | Why? |
Thrombosis | 2 | 2020 | 7504 | 0.08 | Why? |
Male | 16 | 2020 | 367725 | 0.08 | Why? |
Protein Domains | 1 | 2020 | 6563 | 0.08 | Why? |
Blood Coagulation Disorders | 1 | 2020 | 2040 | 0.08 | Why? |
World Health Organization | 1 | 2020 | 4213 | 0.08 | Why? |
Cause of Death | 1 | 2020 | 4823 | 0.08 | Why? |
Oxidative Stress | 1 | 2017 | 2050 | 0.08 | Why? |
Female | 14 | 2020 | 380317 | 0.08 | Why? |
Survival Analysis | 1 | 2020 | 7592 | 0.08 | Why? |
Healthy Lifestyle | 2 | 2021 | 447 | 0.08 | Why? |
Lymphocyte Count | 1 | 2018 | 4758 | 0.08 | Why? |
Blood Platelets | 1 | 2017 | 1704 | 0.08 | Why? |
Adult | 11 | 2020 | 244371 | 0.07 | Why? |
Patient Selection | 1 | 2020 | 4560 | 0.07 | Why? |
Kidney | 1 | 2019 | 3648 | 0.07 | Why? |
Intubation, Intratracheal | 1 | 2021 | 3962 | 0.07 | Why? |
Creatine Kinase | 2 | 2018 | 386 | 0.07 | Why? |
Protein Binding | 1 | 2020 | 11430 | 0.06 | Why? |
Aged, 80 and over | 5 | 2020 | 88759 | 0.06 | Why? |
Lactic Acid | 2 | 2018 | 393 | 0.06 | Why? |
Nursing Homes | 1 | 2020 | 4155 | 0.06 | Why? |
Middle Aged | 10 | 2020 | 270681 | 0.06 | Why? |
RNA, Viral | 2 | 2020 | 32276 | 0.06 | Why? |
Virus Internalization | 1 | 2020 | 7921 | 0.06 | Why? |
Young Adult | 4 | 2020 | 93724 | 0.06 | Why? |
Asymptomatic Infections | 1 | 2020 | 7218 | 0.06 | Why? |
Hospitalization | 4 | 2021 | 54280 | 0.06 | Why? |
Algorithms | 1 | 2018 | 7346 | 0.05 | Why? |
Reproducibility of Results | 1 | 2018 | 11304 | 0.05 | Why? |
Italy | 3 | 2020 | 38444 | 0.05 | Why? |
Cell Size | 1 | 2021 | 106 | 0.05 | Why? |
Leukocyte Count | 2 | 2021 | 3178 | 0.05 | Why? |
Confined Spaces | 1 | 2020 | 37 | 0.05 | Why? |
Host-Pathogen Interactions | 1 | 2020 | 11041 | 0.05 | Why? |
Social Isolation | 1 | 2020 | 5932 | 0.05 | Why? |
Time Factors | 2 | 2020 | 31397 | 0.05 | Why? |
Hypoxia | 1 | 2014 | 3626 | 0.05 | Why? |
Health Behavior | 1 | 2018 | 4449 | 0.05 | Why? |
Registries | 1 | 2019 | 12327 | 0.05 | Why? |
Anticoagulants | 1 | 2020 | 9563 | 0.05 | Why? |
Acute Kidney Injury | 2 | 2017 | 5762 | 0.05 | Why? |
Sensitivity and Specificity | 1 | 2020 | 22971 | 0.05 | Why? |
Aging | 1 | 2015 | 3581 | 0.05 | Why? |
Emergency Service, Hospital | 3 | 2018 | 14232 | 0.05 | Why? |
Incidence | 1 | 2020 | 25622 | 0.04 | Why? |
Energy Intake | 1 | 2020 | 323 | 0.04 | Why? |
Agaricales | 1 | 2017 | 38 | 0.04 | Why? |
Aged | 5 | 2020 | 215776 | 0.04 | Why? |
Adolescent | 4 | 2020 | 86841 | 0.04 | Why? |
Partial Thromboplastin Time | 1 | 2018 | 436 | 0.04 | Why? |
Erythrocyte Count | 1 | 2017 | 137 | 0.04 | Why? |
Clinical Laboratory Techniques | 2 | 2020 | 23402 | 0.04 | Why? |
Factor VIII | 1 | 2018 | 229 | 0.04 | Why? |
SARS Virus | 1 | 2020 | 13021 | 0.04 | Why? |
United States | 2 | 2021 | 46150 | 0.04 | Why? |
Treatment Outcome | 2 | 2020 | 51732 | 0.04 | Why? |
Critical Care | 1 | 2020 | 14081 | 0.04 | Why? |
Myoglobin | 1 | 2017 | 143 | 0.04 | Why? |
Energy Metabolism | 1 | 2020 | 451 | 0.04 | Why? |
Hemoglobinometry | 1 | 2014 | 6 | 0.04 | Why? |
Prospective Studies | 1 | 2020 | 43301 | 0.04 | Why? |
Thrombin | 1 | 2018 | 325 | 0.04 | Why? |
Chemotherapy, Adjuvant | 1 | 2017 | 606 | 0.03 | Why? |
Insulin Resistance | 1 | 2020 | 669 | 0.03 | Why? |
Metabolic Diseases | 1 | 2020 | 505 | 0.03 | Why? |
Eosinophils | 1 | 2021 | 848 | 0.03 | Why? |
Neoadjuvant Therapy | 1 | 2017 | 554 | 0.03 | Why? |
Retrospective Studies | 3 | 2021 | 105322 | 0.03 | Why? |
Tomography, X-Ray Computed | 1 | 2021 | 25144 | 0.03 | Why? |
Analysis of Variance | 1 | 2017 | 950 | 0.03 | Why? |
Cross-Sectional Studies | 1 | 2020 | 53120 | 0.03 | Why? |
Intensive Care Units | 1 | 2020 | 29594 | 0.03 | Why? |
Demography | 1 | 2020 | 1660 | 0.03 | Why? |
von Willebrand Factor | 1 | 2018 | 668 | 0.03 | Why? |
Lipocalin-2 | 1 | 2012 | 156 | 0.03 | Why? |
Linear Models | 1 | 2017 | 1914 | 0.03 | Why? |
Spike Glycoprotein, Coronavirus | 1 | 2020 | 37182 | 0.02 | Why? |
Neoplasms | 1 | 2017 | 17251 | 0.02 | Why? |
Killer Cells, Natural | 1 | 2017 | 2093 | 0.02 | Why? |
Antiviral Agents | 1 | 2020 | 41703 | 0.02 | Why? |
Animals | 1 | 2017 | 78931 | 0.02 | Why? |
Multivariate Analysis | 1 | 2018 | 5440 | 0.02 | Why? |
Smoking | 1 | 2020 | 3358 | 0.02 | Why? |
Quality of Life | 2 | 2017 | 9820 | 0.02 | Why? |
Glomerular Filtration Rate | 1 | 2012 | 1262 | 0.02 | Why? |
Creatinine | 1 | 2012 | 1443 | 0.02 | Why? |
Blood Coagulation | 1 | 2018 | 2768 | 0.02 | Why? |
Gene Expression Regulation | 1 | 2018 | 4020 | 0.02 | Why? |
C-Reactive Protein | 1 | 2021 | 7972 | 0.02 | Why? |
Acute Disease | 1 | 2017 | 6029 | 0.02 | Why? |
Europe | 1 | 2021 | 12702 | 0.02 | Why? |
Predictive Value of Tests | 1 | 2017 | 9537 | 0.01 | Why? |
Patient Discharge | 1 | 2018 | 5696 | 0.01 | Why? |
Disease Progression | 1 | 2020 | 13580 | 0.01 | Why? |
Oxygen | 1 | 2014 | 3715 | 0.01 | Why? |
Real-Time Polymerase Chain Reaction | 1 | 2020 | 11367 | 0.01 | Why? |
Disease Management | 1 | 2017 | 6841 | 0.01 | Why? |
Follow-Up Studies | 1 | 2017 | 17020 | 0.01 | Why? |
Child | 2 | 2018 | 70012 | 0.01 | Why? |
Critical Illness | 1 | 2021 | 17281 | 0.01 | Why? |
Pregnancy | 1 | 2017 | 23879 | 0.01 | Why? |
China | 1 | 2020 | 50654 | 0.01 | Why? |
Sanchis-Gomar's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(236)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(41)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_